{"hands_on_practices": [{"introduction": "Autophagy is a fundamental survival mechanism, tightly regulated by the cell's energy status. This practice explores the primary upstream switch for autophagy initiation, linking the cell's metabolic state to the activation of the ULK1 kinase complex. By calculating how inhibiting a major ATP-producing pathway impacts the cellular energy sensor—the ATP/AMP ratio—you will quantitatively determine the resulting effect on ULK1 activation [@problem_id:2033060]. This exercise will strengthen your ability to link metabolic biochemistry with the signal transduction pathways that govern cellular homeostasis.", "problem": "In a study of cellular metabolic adaptation, a culture of primary hepatocytes is used. In a nutrient-rich medium, these cells maintain a high energy state, characterized by a steady-state ratio of Adenosine Triphosphate (ATP) to Adenosine Monophosphate (AMP) of 100. To induce autophagy, the cells are transferred to a nutrient-free starvation medium. In this starved state, the total rate of ATP production drops to 30% of the rate observed in the nutrient-rich medium.\n\nNext, a subset of these starved cells is treated with a highly specific, non-competitive inhibitor that completely blocks the activity of Carnitine Palmitoyltransferase 1 (CPT1), the enzyme that catalyzes the rate-limiting step of mitochondrial fatty acid beta-oxidation. Under these specific starvation conditions in hepatocytes, it is known that fatty acid beta-oxidation accounts for 65% of the total ATP production.\n\nA simplified model for the activation of autophagy posits that the cellular amount of activated Unc-51 like autophagy activating kinase 1 (ULK1) is inversely proportional to the ATP/AMP ratio. For the purpose of this problem, assume that the cellular AMP concentration remains constant across all conditions, making the ATP/AMP ratio directly proportional to the total cellular ATP production rate.\n\nCalculate the fold-change in the amount of activated ULK1 in cells subjected to both starvation and CPT1 inhibition, relative to cells subjected to starvation alone. Report your answer as a numerical value rounded to three significant figures.", "solution": "Let $R_{\\text{rich}}$ be the total ATP production rate in nutrient-rich medium. Under starvation alone, the total ATP production rate is reduced to a fraction of this:\n$$\nR_{\\text{starve}} = 0.30\\,R_{\\text{rich}}.\n$$\nUnder starvation, fatty acid beta-oxidation contributes a fraction $0.65$ of the total ATP production, so non-fatty-acid sources contribute $1 - 0.65 = 0.35$. Complete CPT1 inhibition abolishes the fatty acid beta-oxidation contribution, leaving only the non-fatty-acid contribution. Therefore, under starvation plus CPT1 inhibition, the total ATP production rate is\n$$\nR_{\\text{inh}} = 0.35\\,R_{\\text{starve}} = 0.35 \\times 0.30\\,R_{\\text{rich}}.\n$$\nLet the ATP/AMP ratio be proportional to the ATP production rate due to constant AMP concentration: there exists $k>0$ such that\n$$\n\\frac{\\text{ATP}}{\\text{AMP}} = k\\,R.\n$$\nThe activated ULK1 amount $U$ is inversely proportional to the ATP/AMP ratio, so there exists $c>0$ such that\n$$\nU = \\frac{c}{\\frac{\\text{ATP}}{\\text{AMP}}} = \\frac{c}{k\\,R} = \\frac{C}{R},\n$$\nwhere $C \\equiv c/k$ is a positive constant.\n\nThe fold-change in activated ULK1 for starvation plus CPT1 inhibition relative to starvation alone is\n$$\n\\text{Fold} = \\frac{U_{\\text{inh}}}{U_{\\text{starve}}} = \\frac{C/R_{\\text{inh}}}{C/R_{\\text{starve}}} = \\frac{R_{\\text{starve}}}{R_{\\text{inh}}}.\n$$\nSubstituting $R_{\\text{inh}} = 0.35\\,R_{\\text{starve}}$ gives\n$$\n\\text{Fold} = \\frac{R_{\\text{starve}}}{0.35\\,R_{\\text{starve}}} = \\frac{1}{0.35} = \\frac{20}{7} \\approx 2.857142857\\ldots\n$$\nRounded to three significant figures, this is $2.86$.", "answer": "$$\\boxed{2.86}$$", "id": "2033060"}, {"introduction": "Once a cell receives the signal to initiate autophagy, a sophisticated molecular machinery assembles the autophagosome. This thought experiment guides you through dissecting this process by examining the consequences of removing a critical component, the Atg5 protein [@problem_id:2033100]. You will predict the molecular state of the cell, focusing on key markers like the cargo receptor p62/SQSTM1 and the conversion of LC3-I to its lipidated form, LC3-II, thereby clarifying the essential role of the Atg conjugation systems in autophagosome elongation.", "problem": "A research team is investigating autophagy, a fundamental cellular process for degrading and recycling damaged organelles and long-lived proteins. To do this, they generate a knockout cell line that lacks a functional gene for Autophagy Related 5 (Atg5). In wild-type cells, the autophagy pathway involves the formation of a double-membraned vesicle, the autophagosome, which engulfs the cellular material destined for degradation. A crucial step in this process is the covalent attachment of the protein LC3-I to a lipid molecule, converting it to its membrane-bound form, LC3-II. This LC3-II is essential for the elongation of the autophagosome membrane. Another protein, p62/SQSTM1, acts as a cargo adaptor by binding to ubiquitinated substrates and also to LC3-II, thereby targeting the cargo into the forming autophagosome for degradation. Consequently, p62/SQSTM1 itself is degraded during a successful autophagic cycle.\n\nThe team compares the wild-type cells with the Atg5 knockout cells after subjecting both to nutrient starvation, a condition known to be a potent inducer of autophagy. Which of the following describes the most likely molecular and cellular state of the Atg5 knockout cells compared to the wild-type cells under these conditions?\n\nA. A block in the initiation of the phagophore due to the inability of the ULK1 complex to become activated, resulting in a failure to recruit downstream autophagy machinery.\n\nB. An accumulation of fully formed, cargo-filled autophagosomes that are unable to fuse with lysosomes, leading to high cellular levels of both LC3-II and p62/SQSTM1.\n\nC. A failure in the elongation of the autophagosome membrane due to the inability to convert LC3-I to LC3-II, resulting in an accumulation of the cargo adaptor protein p62/SQSTM1 and its associated cargo.\n\nD. An unregulated, hyperactive autophagic response leading to excessive degradation of cellular components and a rapid depletion of both LC3-I and p62/SQSTM1.", "solution": "Autophagy proceeds through ordered stages: initiation (ULK1 complex activation), nucleation (class III PI3K complex), elongation and closure of the phagophore into an autophagosome (requiring the Atg12–Atg5–Atg16L1 conjugation system and LC3 lipidation), followed by fusion with lysosomes and degradation of cargo. LC3 is processed from LC3-I (cytosolic) to LC3-II (phosphatidylethanolamine-conjugated, membrane-bound) in a reaction that requires the Atg12–Atg5–Atg16L1 complex, which functions as an E3-like ligase for LC3 lipidation. p62/SQSTM1 binds ubiquitinated cargo and LC3-II to deliver cargo into the forming autophagosome and is itself degraded when autophagic flux is intact.\n\nIn Atg5 knockout cells:\n- The initiation machinery (ULK1 complex) can still be activated by starvation, so initiation is not blocked, excluding option A.\n- The critical defect is at the elongation step: without Atg5, the Atg12–Atg5–Atg16L1 complex cannot form, LC3-I cannot be converted to LC3-II, and the phagophore fails to elongate and close. Consequently, LC3-II is not generated, and fully formed autophagosomes do not accumulate. Therefore, a phenotype of accumulated, cargo-filled autophagosomes with high LC3-II is not expected, excluding option B.\n- Because autophagic flux is impaired upstream of lysosomal fusion, cargo receptors such as p62/SQSTM1 are not delivered for degradation and thus accumulate. This matches a block at LC3 lipidation/elongation, supporting option C.\n- Starvation-induced autophagy cannot become hyperactive in the absence of an essential elongation factor; thus unregulated hyperactivation with depletion of LC3-I and p62 is not plausible, excluding option D.\n\nTherefore, the most likely state is failure of autophagosome membrane elongation due to inability to convert LC3-I to LC3-II, with accumulation of p62/SQSTM1 and its cargo, as described in option C.", "answer": "$$\\boxed{C}$$", "id": "2033100"}, {"introduction": "Measuring autophagy is not as simple as counting autophagosomes; what truly matters is the dynamic rate of their formation and degradation, a concept known as autophagic flux. This practice illustrates this crucial principle by simulating an experiment where the final step—the fusion of autophagosomes with lysosomes—is blocked [@problem_id:2033068]. By predicting the effect on the level of the autophagosome marker LC3-II, you will learn to distinguish a block in degradation from a true increase in autophagic activity, a critical skill for interpreting experimental results.", "problem": "A cell biologist is investigating the process of autophagy, a cellular degradation pathway crucial for homeostasis. A key step in this pathway is the formation of a double-membraned vesicle called an autophagosome, which engulfs cytoplasmic components. The protein Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a well-established marker for autophagosomes. In its cytosolic form (LC3-I), it is processed and conjugated to the lipid phosphatidylethanolamine (PE) to form LC3-II. This lipidated form, LC3-II, is then recruited to and integrated into the inner and outer membranes of the growing autophagosome. The final step of the canonical autophagic pathway involves the fusion of the autophagosome with a lysosome, forming an autolysosome. Inside the autolysosome, the engulfed contents and the inner autophagosomal membrane (along with its associated LC3-II) are degraded by lysosomal hydrolases.\n\nThe biologist treats a culture of healthy, actively dividing cells with a novel experimental compound, \"Inhibifusin-A\". This compound is known to specifically and completely block the fusion of autophagosomes with lysosomes, but it does not affect the initial steps of autophagosome formation or the degradative capacity of the lysosomes themselves. After a sufficient treatment period, the biologist collects the cells, prepares a lysate, and uses a Western blot to measure the total cellular amount of LC3-II.\n\nWhich of the following outcomes would be the most likely observation for the level of LC3-II in the Inhibifusin-A treated cells compared to an identical culture of untreated control cells?\n\nA. A significant decrease in the amount of LC3-II.\n\nB. A significant increase in the amount of LC3-II.\n\nC. No significant change in the amount of LC3-II.\n\nD. The complete disappearance of LC3-II, with a corresponding increase in LC3-I.\n\nE. A transient increase in LC3-II, followed by a rapid decrease to below the level of the untreated control.", "solution": "We first restate the relevant biology and define variables for a kinetic argument. LC3 exists in a cytosolic form, LC3-I, that is lipidated to LC3-II and incorporated into autophagosomal membranes during autophagosome biogenesis. Fusion of autophagosomes with lysosomes forms autolysosomes, where the inner autophagosomal membrane and its associated LC3-II are degraded by lysosomal hydrolases; LC3-II on the outer membrane is delipidated and recycled. The compound Inhibifusin-A blocks only the fusion step, without affecting autophagosome formation or lysosomal degradative capacity.\n\nLet $L_{\\mathrm{II}}(t)$ denote the total cellular amount of LC3-II at time $t$. Let $J_{\\mathrm{form}}$ be the net formation flux of LC3-II (conversion from LC3-I and incorporation into autophagosomal membranes), which is unaffected by the treatment, and let $J_{\\mathrm{rem}}$ be the net removal flux of LC3-II (degradation in autolysosomes of inner-membrane LC3-II plus delipidation/recycling that depends on successful fusion). At baseline steady state in untreated cells, autophagic flux implies\n$$\n\\frac{dL_{\\mathrm{II}}}{dt}=J_{\\mathrm{form}}-J_{\\mathrm{rem}}=0 \\quad \\Rightarrow \\quad J_{\\mathrm{form}}=J_{\\mathrm{rem}}.\n$$\nUpon treatment with Inhibifusin-A, the fusion step is completely blocked while earlier steps proceed, so the removal flux that depends on fusion is eliminated:\n$$\nJ_{\\mathrm{rem}} \\to 0.\n$$\nTherefore, during treatment,\n$$\n\\frac{dL_{\\mathrm{II}}}{dt}=J_{\\mathrm{form}}-0=J_{\\mathrm{form}} \\quad \\text{with} \\quad J_{\\mathrm{form}}>0,\n$$\nwhich implies $L_{\\mathrm{II}}(t)$ increases monotonically over time relative to the untreated steady state. After a sufficient treatment period, the accumulated LC3-II will be significantly higher than in untreated control cells.\n\nThis excludes the alternatives: a decrease (A) would require increased removal, which does not occur; no change (C) would require $J_{\\mathrm{form}}=0$, contradicting preserved formation; disappearance with LC3-I increase (D) would require enhanced conversion of LC3-II back to LC3-I or enhanced degradation, neither of which occurs without fusion; a transient increase followed by a rapid decrease (E) would require restoration or enhancement of removal, which is blocked throughout the treatment. The most likely observation is a significant increase in LC3-II levels.\n\nHence, the correct choice is B.", "answer": "$$\\boxed{B}$$", "id": "2033068"}]}